1. Home
  2. AZTR vs WLGS Comparison

AZTR vs WLGS Comparison

Compare AZTR & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • WLGS
  • Stock Information
  • Founded
  • AZTR 2014
  • WLGS 1981
  • Country
  • AZTR United States
  • WLGS Hong Kong
  • Employees
  • AZTR N/A
  • WLGS N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • WLGS Engineering & Construction
  • Sector
  • AZTR Health Care
  • WLGS Consumer Discretionary
  • Exchange
  • AZTR Nasdaq
  • WLGS Nasdaq
  • Market Cap
  • AZTR 3.7M
  • WLGS 3.0M
  • IPO Year
  • AZTR 2023
  • WLGS 2023
  • Fundamental
  • Price
  • AZTR $0.16
  • WLGS $0.05
  • Analyst Decision
  • AZTR
  • WLGS
  • Analyst Count
  • AZTR 0
  • WLGS 0
  • Target Price
  • AZTR N/A
  • WLGS N/A
  • AVG Volume (30 Days)
  • AZTR 1.0M
  • WLGS 147.7M
  • Earning Date
  • AZTR 08-11-2025
  • WLGS 08-26-2025
  • Dividend Yield
  • AZTR N/A
  • WLGS N/A
  • EPS Growth
  • AZTR N/A
  • WLGS N/A
  • EPS
  • AZTR N/A
  • WLGS N/A
  • Revenue
  • AZTR N/A
  • WLGS $3,951,649.00
  • Revenue This Year
  • AZTR N/A
  • WLGS N/A
  • Revenue Next Year
  • AZTR N/A
  • WLGS N/A
  • P/E Ratio
  • AZTR N/A
  • WLGS N/A
  • Revenue Growth
  • AZTR N/A
  • WLGS N/A
  • 52 Week Low
  • AZTR $0.14
  • WLGS $0.03
  • 52 Week High
  • AZTR $0.80
  • WLGS $9.66
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 33.84
  • WLGS 46.16
  • Support Level
  • AZTR $0.14
  • WLGS $0.05
  • Resistance Level
  • AZTR $0.16
  • WLGS $0.07
  • Average True Range (ATR)
  • AZTR 0.01
  • WLGS 0.01
  • MACD
  • AZTR -0.00
  • WLGS 0.00
  • Stochastic Oscillator
  • AZTR 26.81
  • WLGS 37.22

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About WLGS Wang & Lee Group Inc.

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.

Share on Social Networks: